Healthcare -
Biotechnology - NASDAQ - US
$ 4.83
6.39 %
$ 218 M
Market Cap
-7.21
P/E
YMAB - TOTAL CURRENT ASSETS
Total Current Assets YMAB - Y-mAbs Therapeutics, Inc.
98.5 M
LAST VALUE
-13.10%
2 YEAR CAGR
-14.21%
5 YEAR CAGR
0.00%
10 YEAR CAGR